Osteoporosis in men

Area of Science:

• Endocrinology
• Bone Metabolism
• Geriatrics

Background:

• Osteoporosis in men contributes significantly to morbidity, mortality, and healthcare costs in Western countries.
• While many cases are secondary to identifiable conditions or treatments, 30-45% are classified as 'idiopathic' male osteoporosis.
• Emerging research suggests a critical role for sex hormones, specifically androgens and oestrogens, in maintaining male bone health.

Purpose of the Study:

• To review the current understanding of male osteoporosis, focusing on underlying factors and potential treatments.
• To explore the contribution of sex hormones to bone health in men.
• To identify common predisposing conditions and discuss therapeutic options for male osteoporosis.

Main Methods:

• Literature review of studies on male osteoporosis.
• Analysis of factors contributing to secondary and idiopathic osteoporosis in men.
• Evaluation of current treatment strategies and their evidence base.

Main Results:

• Identified hypogonadism, alcohol abuse, and corticosteroid use as frequent predisposing factors for male osteoporosis.
• Highlighted the importance of androgens and oestrogens for normal bone health in men.
• Noted that osteoporosis following organ transplantation is a recognized, albeit rare, condition.

Conclusions:

• Male osteoporosis is multifactorial, with increasing recognition of secondary causes.
• Sex hormones play a vital role in male bone health, and their imbalance can lead to osteoporosis.
• While treatment options like bisphosphonates and testosterone show promise, further research is needed; symptom management remains key.